Boc-Phe-Leu-Phe-Leu-Phe

A competitive antagonist of the binding of For-Met-Leu-Phe-OH to neutrophils.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Boc-Phe-Leu-Phe-Leu-Phe(CAS 73572-58-4)

CAT No: R1913

CAS No:73572-58-4

Synonyms/Alias:Boc-phe-leu-phe-leu-phe;Boc-flflf;148182-34-7;Boc-phe(D)-leu-phe(D)-leu-phe-OH;73572-58-4;Boc-Phe-Leu-Phe-Leu-Phe-OH;(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid;tert-Butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanyl-OH;L-Phenylalanine, N-(N-(N-(N-(N-((1,1-dimethylethoxy)carbonyl)-D-phenylalanyl)-L-leucyl)-D-phenylalanyl)-L-leucyl)-;BOCPheLeuPheLeuPhe;(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-PHENYLPROPANAMIDO]-4-METHYLPENTANAMIDO]-3-PHENYLPROPANAMIDO]-4-METHYLPENTANAMIDO]-3-PHENYLPROPANOIC ACID;Boc2; Boc-FLFLF;BOC-PLPLP;SCHEMBL3046634;DTXSID10933330;NGNZQSPFQJCBJQ-LTLCPEALSA-N;C44H59N5O8;MFCD00076350;DA-58423;FB111222;G12220;n-t-butoxycarbonyl-l-phenylalanyl-l-leucyl-l-phenylalanyl-l-leucyl-l-phenylalanine;(6S,9S,12S,15S,18S)-6,12,18-tribenzyl-9,15-diisobutyl-2,2-dimethyl-4,7,10,13,16-pentaoxo-3-oxa-5,8,11,14,17-pentaazanonadecan-19-oic acid;N-[6,12-Dibenzyl-4,7,10,13,16-pentahydroxy-2,2-dimethyl-9,15-bis(2-methylpropyl)-3-oxa-5,8,11,14-tetraazahexadeca-4,7,10,13-tetraen-16-ylidene]phenylalanine;

Chemical Name:(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C44H59N5O8
M.W/Mr.
786
Sequence
One Letter Code: FLFLF
Three Letter Code: Boc-Phe-Leu-Phe-Leu-Phe-OH
Application
Immunomodulating Agents
Activity
Antagonist

Boc-Phe-Leu-Phe-Leu-Phe is a synthetic peptide composed of a sequence of phenylalanine (Phe) and leucine (Leu) residues, N-terminally protected with a tert-butyloxycarbonyl (Boc) group. As a well-defined oligopeptide, it serves as a valuable model compound in peptide chemistry and biochemistry research, offering insights into peptide folding, hydrophobic interactions, and sequence-dependent behavior. The alternating aromatic and aliphatic residues confer unique physicochemical properties, making this peptide particularly relevant for studies exploring structure-activity relationships, peptide-membrane interactions, and the development of peptide-based materials or bioactive probes.

Peptide synthesis validation: Boc-Phe-Leu-Phe-Leu-Phe is frequently used as a standard or reference compound in the development and optimization of solid-phase peptide synthesis (SPPS) protocols. Its defined sequence, featuring both aromatic and aliphatic side chains, enables researchers to assess coupling efficiency, deprotection strategies, and resin compatibility. By monitoring the synthesis of this peptide, laboratories can troubleshoot synthetic challenges, compare different coupling reagents, and refine purification workflows for more complex peptide targets.

Peptide folding and conformational analysis: The sequence of Boc-Phe-Leu-Phe-Leu-Phe, with alternating hydrophobic residues, provides an excellent model for investigating peptide secondary structure formation and the influence of side-chain composition on backbone conformation. Researchers utilize this peptide in spectroscopic studies, such as circular dichroism (CD) and nuclear magnetic resonance (NMR), to elucidate folding patterns, intramolecular interactions, and the impact of sequence design on structural stability. These insights contribute to the broader understanding of protein folding and the rational design of functional peptides.

Membrane interaction studies: Due to its amphipathic character, this peptide is employed in research focused on peptide-membrane interactions and the mechanisms underlying membrane association, insertion, or disruption. It serves as a model system for characterizing the binding affinity and orientation of hydrophobic peptides with lipid bilayers, using biophysical techniques including fluorescence spectroscopy and calorimetry. Such studies inform the development of membrane-active peptides and shed light on fundamental aspects of biomembrane dynamics.

Proteolytic stability assessment: Boc-Phe-Leu-Phe-Leu-Phe is utilized to evaluate the susceptibility of synthetic peptides to enzymatic degradation by various proteases. By incubating the peptide with specific enzymes and monitoring cleavage patterns, researchers can assess stability profiles and identify sequence motifs that confer resistance or sensitivity to proteolysis. These findings are crucial for designing peptides with enhanced bioavailability and longevity in biochemical assays or industrial applications.

Peptide-based material development: The physicochemical properties of Boc-Phe-Leu-Phe-Leu-Phe, particularly its propensity for self-association through hydrophobic and π-π stacking interactions, make it a candidate for the study of peptide-based supramolecular assemblies and nanomaterials. Investigations into its aggregation behavior and the formation of ordered structures provide valuable information for the design of peptide hydrogels, nanofibers, or scaffolds with potential applications in biomaterials science and nanotechnology. Through such studies, this peptide supports the advancement of innovative materials with tunable properties and functional versatility.

Long-term Storage Conditions
Soluble in DMSO
Shipping Condition
Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
InChI
InChI=1S/C44H59N5O8/c1-28(2)23-33(46-41(53)36(26-31-19-13-9-14-20-31)49-43(56)57-44(5,6)7)38(50)47-35(25-30-17-11-8-12-18-30)40(52)45-34(24-29(3)4)39(51)48-37(42(54)55)27-32-21-15-10-16-22-32/h8-22,28-29,33-37H,23-27H2,1-7H3,(H,45,52)(H,46,53)(H,47,50)(H,48,51)(H,49,56)(H,54,55)/t33-,34-,35-,36-,37-/m0/s1
InChI Key
NGNZQSPFQJCBJQ-LTLCPEALSA-N
Canonical SMILES
CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C
Isomeric SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)OC(C)(C)C

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide Synthesis ServicesPeptide Analysis ServicescGMP Peptide ServicePeptide CDMOEpitope Mapping ServicesCustom Conjugation ServicePeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers